what is ipamorelin Peptide Therapy in Scottsdale & Peoria Arizona Ipamorelin | Peak Biosciences

This peptide has also not been approved by the FDA for human consumption and should be used for research purposes only

This product is intended for research purposes only

(Eur J Endocrinol 1998) reported that ipamorelin stimulated GH release from anterior pituitary somatotrophs via GHSR-1a (Gq/11PLCIP pathway) at doses up to 200-fold its GH-effective dose without significantly elevating ACTH, cortisol, FSH, LH, prolactin, or TSH above GHRH-stimulated controls in rats

Unlike metabolic peptides such as Retatrutide vs Tirzepatide or MOTS-c vs 5-Amino-1MQwhich target insulin, GLP-1, or NAD+ pathwaysCJC-1295 and Ipamorelin target the hypothalamic-pituitary axis

Without DAC (Mod GRF 1-29), the half-life is around 30 minutes, requiring more frequent dosing but preserving the natural pulsatile GH release pattern